Patrick Collison and tech leaders put $500M into Intercept to eliminate the flu and all respiratory viruses
Key Points
- Stripe CEO Patrick Collison, OpenAI, Anthropic, and Bill Gates commit $500 million to Intercept, a nonprofit targeting prevention of the common cold, flu, and all respiratory viruses.
- Parents with three or four children are sick roughly 50 percent of the year with viral infections, creating a disease burden that tech leaders believe a vaccine-like solution would directly and visibly reduce.
- The initiative appeals to major tech figures because respiratory virus prevention offers immediate household-level feedback, unlike most biotech efforts with delayed or abstract health gains.
Summary
Stripe, OpenAI, Anthropic, and Bill Gates Back $500M Respiratory Virus Initiative
Stripe CEO Patrick Collison has joined OpenAI, Anthropic, and Bill Gates in committing $500 million to a new nonprofit called Intercept, aimed at preventing the common cold, flu, and eventually all respiratory viruses.
The funding represents a significant bet by major tech leaders on a public health problem with immediate, felt impact. The case is straightforward: parents with multiple children face a steep disease burden. One analysis cited in the segment shows that parents with one child are sick roughly 25 percent of the year with some viral infection, a figure that climbs to roughly 50 percent among parents with three or four children. That curve is steep enough that Collison believes a win here would be broadly understood and celebrated—the kind of tangible health gain the tech industry needs.
The appeal lies partly in how directly people would feel progress. Unlike many biotech efforts, respiratory virus prevention offers immediate, household-level feedback: fewer sick days, clearer schedules, less perpetual low-grade illness cycling through families.
Every deal, every interview. 5 minutes.
TBPN Digest delivers summaries of the latest fundraises, interviews and tech news from TBPN, every weekday.